论文部分内容阅读
目的探讨法舒地尔治疗椎基底动脉供血不足性眩晕的疗效。方法选择62例椎基底动脉供血不足性眩晕患者,随机分为治疗组32例和对照组30例,治疗组采用盐酸法舒地尔30mg静脉滴注,1次/d。对照组采用复方丹参粉针0.4g静脉滴注,1次/d,14d为1个疗程。结果盐酸法舒地尔组总有效率为93.75%,高于对照组的63.33%(P<0.05),具有统计学意义。结论盐酸法舒地尔治疗椎基底动脉缺血性眩晕疗效确切。
Objective To investigate the efficacy of fasudil in the treatment of Vertebrobasilar insufficiency vertigo. Methods Sixty-two patients with vertebrobasilar insufficiency vertigo were randomly divided into treatment group (n = 32) and control group (n = 30). The treatment group was given fasudil 30 mg intravenously once daily. The control group received compound Danshen powder injection 0.4g intravenously, once / d, 14d for a course of treatment. Results The total effective rate of fasudil hydrochloride group was 93.75%, which was higher than 63.33% (P <0.05) of the control group, with statistical significance. Conclusion Fasudil hydrochloride is effective in treating vertebrobasilar ischemic vertigo.